LakeShore Biopharma Co., Ltd (LSB)

NASDAQ: LSB · IEX Real-Time Price · USD

0.490

-0.010 (-2.02%)

At close: Jul 19, 2024, 4:00 PM

0.410

-0.080 (-16.31%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

LakeShore Biopharma Cash Flow Statement

Financials in millions CNY. Fiscal year is April - March.

Millions CNY. Fiscal year is Apr - Mar.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	-421.46	-367.33	-225.05
Depreciation & Amortization	-	41.11	34.94	30.14
Share-Based Compensation	-	3.51	7.76	76.76
Other Operating Activities	-	56.38	20.42	-145.07
Operating Cash Flow	-	-182.47	-173.55	-246.61
Capital Expenditures	-	-52.69	-295.31	-104.24
Other Investing Activities	-	-4.29	-3.62	-
Investing Cash Flow	-	-56.98	-298.92	-104.24
Share Issuance / Repurchase	-	0	0	731
Debt Issued / Paid	-	100.88	364.56	8.26
Other Financing Activities	-	216.57	-	-
Financing Cash Flow	-	317.45	364.56	739.26
Exchange Rate Effect	-	21.3	-11.48	-0
Net Cash Flow	-	99.3	-119.39	388.41
Free Cash Flow	-	-235.16	-468.85	-350.85
Free Cash Flow Margin	-	-34.22%	-93.22%	-136.51%
Free Cash Flow Per Share	-	-2.53	-7.58	-5.67

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).